<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60384">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01891435</url>
  </required_header>
  <id_info>
    <org_study_id>9070/09</org_study_id>
    <nct_id>NCT01891435</nct_id>
  </id_info>
  <brief_title>The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.</brief_title>
  <official_title>A Randomized Controlled Clinical Trial on the Antipyretic Efficacy of Oral Paracetamol, Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever to Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamad Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hamad Medical Corporation</source>
  <oversight_info>
    <authority>Qatar: Hamad Medical Corporation</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized clinical trial to check the antipyretic efficacy of oral and intravenous
      paracetamol and intramuscular diclofenac sodium in patients presenting with fever to
      emergency department.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Reduction in temperature in every thirty minutes till 120 minutes after receiving antipyretics</measure>
    <time_frame>Reduction in temperature is checked every 30 minutes for a maximum of 120 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Once the patients fulfill the inclusion criteria, they are randomly assigned to receive one of the three medications in the study ( oral paracetamol,  intravenous paracetamol or intramuscular diclofenac). Baseline temperature is recorded using a standard thermometer. Then reduction in temperature is recorded every 30 minutes for 2 hours.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">434</enrollment>
  <condition>Fever</condition>
  <condition>Reduction in Temperature</condition>
  <arm_group>
    <arm_group_label>oral paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this arm will receive 1000mg of oral paracetamol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this arm will receive 1000 mg of intravenous paracetamol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intramuscular Diclofenac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this arm will receive 75 mg of intramuscular diclofenac sodium</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral paracetamol</intervention_name>
    <description>after giving medicine temperature is checked every 30 minutes for 2 hours</description>
    <arm_group_label>oral paracetamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous paracetamol</intervention_name>
    <description>after giving medicine temperature is checked every 30 minutes for 2 hours</description>
    <arm_group_label>Intravenous paracetamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intramuscular diclofenac</intervention_name>
    <description>after giving medicine temperature is checked every 30 minutes for 2 hours</description>
    <arm_group_label>Intramuscular Diclofenac</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults between the age of 14-75 years with an oral temperature of more than 38.5 C

        Exclusion Criteria:

          -  History of allergy to any of the drugs in the study

          -  Had taken antipyretics within 8 hours

          -  Renal, hepatic or haematological disorders

          -  bronchial asthma, peptic ulcer disease, vomiting

          -  Pregnant or lactating women
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>osama H Mohammed</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamad Medical Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hamad medical corporation</name>
      <address>
        <city>Doha</city>
        <zip>3050</zip>
        <country>Qatar</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Qatar</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 28, 2013</lastchanged_date>
  <firstreceived_date>June 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hamad Medical Corporation</investigator_affiliation>
    <investigator_full_name>Firjeeth C Paramba</investigator_full_name>
    <investigator_title>Specialist, Emergency Department</investigator_title>
  </responsible_party>
  <keyword>antipyretics</keyword>
  <keyword>oral paracetamol</keyword>
  <keyword>intravenous paracetamol</keyword>
  <keyword>intramuscular diclofenac</keyword>
  <keyword>emergency department</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Antipyretics</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
